// App-Quantinova.ai

TMOD-25 : LATENT SOX9-POSITIVE CELLS BEHIND MYC-DRIVEN MEDULLOBLASTOMA RELAPSE

Researchers

Presenter

  • Anna Borgenvik

Principal Investigators

  • Vasil Savov

  • Karl O Holmberg

  • Miao Zhao

  • Gabriela Rosen

  • Sonja Hutter

  • Alexandra Garancher

  • Aldwin Suryo Rahmanto

  • Tobias Bergstrom

  • Oliver Mainwaring

  • Damiana Sattanino

  • Annemieke D Verbaan

  • Jessica Rusert

  • Anders Sundstrom

  • Yonglong Dang

  • Amelie Wenz

  • Stacey Richardson

  • Grammatiki Fotaki

  • Geraldine Giraud

  • Rebecca Hill

  • Adrian Dubuc

  • Antonia Kalushkova

  • Marc Remke

  • Matko Cancer

  • Helena Jernberg-Wiklund

  • xingqi Chen

  • Michael D Taylor

  • Olle Sangfelt

  • Steven Clifford

  • Ulrich Schuller

  • Robert Wechsler-Reya

  • Holger Weishaupt

  • Fredrik Swartling

Medical Centers

  • n/a, Moncalieri, Italy

  • N/A, N/A, CA, USA

  • Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK

  • Karolinska Institute, Department of Oncology and Pathology, Stockholm, Sweden

  • Newcastle University Centre for Cancer & Professor of Molecular Paediatric Oncology, Newcastle upon Tyne, UK

  • n/a, Athens, Aitolia kai, Akarnania, Greece

  • Uppsala University, Department of Pharmaceutical Biosciences, Uppsala, Sweden

  • Uppsala University, IGP, Uppsala, Sweden

  • Institute of Molecular Biology Mainz, Mainz, Germany

  • Department of Pediatric Hematology and Oncology, University Medical Center Eppendorf, Hamburg, Germany

  • Brigham and Women's Hospital, Pathology, Boston, MA, USA

  • Department of Immunology, Genetics and Pathology, Uppsala, Uppsala Lan, Sweden

  • Department of Surgery and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada

  • Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA

  • Department of Pediatric Oncology, Hematology and Clinical Immunology German Cancer Consortium (DKTK), University Hospital Düsseldorf, Duesseldorf, Germany

  • Uppsala University, IGP, Haag, Netherlands

  • N/A, Sofia, Bulgaria

Locations

  • Italy

  • Sweden

  • Germany

  • United States

  • Greece

  • United Kingdom

  • Netherlands

  • Bulgaria

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Medulloblastoma

  • Brain cancer

Biomarkers

  • O-6-methylguanine DNA methyltransferase

Drug/Treatment

  • Doxycycline

  • Doxorubicin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved